Manuela Berger

AbbVie (United States) · US

Area of research

Pharmacology · Cardiology and Cardiovascular Medicine

Research interest

Research interests include Medicine, Randomized controlled trial, Internal medicine, Clinical endpoint, Celecoxib, and Open label.

h-index

—

citations

works

NIH funding

—

primary concept

—

Recent publications

GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial

The American Journal of Gastroenterology 2013cited by 68position: lastdoi

GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial

Arthritis Research & Therapy 2012cited by 17position: lastdoi

No grants ingested yet.

Gurkirpal Singh · Palo Alto University2 papers (2012–2013)Byron Cryer · Southwestern Medical Center2 papers (2012–2013)Lee S. Simon · University of Rochester2 papers (2012–2013)Martin Stillman · University of Minnesota, Twin Cities2 papers (2012–2013)Chunming Li · Fudan University2 papers (2012–2013)

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.